🇨🇳 Country Profile

China

Expanding pharmaceutical supply to China

🇨🇳 $286M
All data from DGCIS India export records (fiscal year, April–March).
$286M
Scale
China's healthcare system receives $286M in Indian pharmaceutical products each year, affordable, quality medicine.
64%
Medicine
Primarily medicine ingredients (64%), supplemented by medicines and traditional & herbal.
2.6×
Trajectory
India's pharmaceutical supply to China has grown 2.6× over the past decade, strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
Impact
Indian pharmaceutical companies have both exported to and invested directly in China, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicine Ingredients $182M (63.6%) Medicines $80.7M (28.2%) Traditional & Herbal $16.2M (5.7%) Surgical & Hospital Supplies $7.0M (2.5%) Vaccines $0.24M (0.1%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in China Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into China: $23.6M across 14 filings (2011-2020).